The Effectiveness of Non-Invasive Ventilation Use in Preterm Infants.
Effectiveness of Synchronized Non-Invasive Ventilation to Prevent Invasive Mechanical Ventilation Use in Preterm Infants.
Prospective observational study of SNIPPV use in preterm infants of less than 32weeks of gestation from January 2012 to December 2015. Previous respiratory status is analyzed as well as respiratory outcomes and possible secondary side effects.
SNIPPV is used to prevent Intubation in Infants in which nCPAP has already failed (Infants that met intubation criteria) and also is used electively for extubation when nCPAP extubation has previously failed or infants with Prolonged mechanical ventilation (more than 15 days) with high respiratory parameters (PMAP > 10 cmH2O and FiO2>35%).
연구 개요
상세 설명
연구 유형
등록 (실제)
연락처 및 위치
연구 장소
-
-
-
Madrid, 스페인, 28033
- Cristina Ramos-Navarro
-
-
참여기준
자격 기준
공부할 수 있는 나이
건강한 자원 봉사자를 받아들입니다
연구 대상 성별
샘플링 방법
연구 인구
Prospective observational study of SNIPPV use in preterm infants of less than 32 weeks of gestation from January 2012 to December of 2014.
SNIPPV is used for:
- nCPAP failure: Preterm infants supported with nCPAP that meet intubation criteria (FiO2>50%; apnea spells more than 4/h or more than 1 that needs PPV) if they are in a stable situation. SAP (systemic arterial pressure)> P10 with preserved respiratory drive (no more than 6 apneas episodes per hour or more than 2 requiring PPI).
Electively For extubation:
- Preterm infants in which nCPAP extubation has previously failed or Prolonged mechanical ventilation (more than 15 days) with high respiratory parameters (PMAP > 10 cmH2O and FiO2>35%).
설명
Inclusion Criteria:
- Preterm Infants of less than 32 weeks of GA in which SNIPPV is applied for nCPAP failure.
- Preterm Infants of less than 32 weeks of GA in which SNIPPV is applied electively for extubation.
Exclusion Criteria: None
공부 계획
연구는 어떻게 설계됩니까?
디자인 세부사항
코호트 및 개입
그룹/코호트 |
개입 / 치료 |
|---|---|
|
Preterm Infants treated with non-invasive ventilation
Preterm Infants of less than 32 weeks of Gestational age treated with synchronized non-invasive ventilation (SNIPPV) to prevent intubation or extubation failure based in a prospective protocol:
Preterm infants in which nCPAP extubation has previously failed or Prolonged mechanical ventilation (more than 15 days) with high respiratory parameters (PMAP > 10 cmH2O and FiO2>35%). |
다른 이름들:
|
연구는 무엇을 측정합니까?
주요 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Avoid of Invasive Mechanical Ventilation in the next three days.
기간: through study completion, an average of 1 year
|
The rate of infants treated with non-invasisive ventilation that do not need to be intubated in the next three days.
|
through study completion, an average of 1 year
|
2차 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Time on MV
기간: through study completion, an average of 1 year
|
Days on MV during hospitalitation
|
through study completion, an average of 1 year
|
|
Neurological impairment
기간: through study completion, an average of 1 year
|
Intraventricular hemorrhage grade 3 or 4 (papile´s classification)
|
through study completion, an average of 1 year
|
|
Rate of patients with air leaks
기간: through study completion, an average of 1 year
|
pulmonary air leak
|
through study completion, an average of 1 year
|
공동 작업자 및 조사자
수사관
- 수석 연구원: Cristina Ramos-Navarro, Gregorio Maranon Hospital
연구 기록 날짜
연구 주요 날짜
연구 시작
기본 완료 (실제)
연구 완료 (실제)
연구 등록 날짜
최초 제출
QC 기준을 충족하는 최초 제출
처음 게시됨 (추정)
연구 기록 업데이트
마지막 업데이트 게시됨 (실제)
QC 기준을 충족하는 마지막 업데이트 제출
마지막으로 확인됨
추가 정보
이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .